Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Chao

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|May 7, 2019
Real-World Outcomes and Factors Associated With the Second-Line Treatment of Patients With Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaAfsaneh Barzi, Lisa M Hess, Yajun E Zhu, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 3, 2016
Assessment of the Double-Staple Technique for Esophagoenteric Anastomosis in Gastric CancerAudrey H Choi, Amanda Arrington, Ann Falor, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 2, 2014
Validation and feasibility of a caloric expenditure measuring device in women with early-stage breast cancerSarah Waliany, Christina M Dieli-Conwright, Paul H Frankel, et al.
Pathology, Research and Practice|February 25, 2020
High-level FGFR2 amplification is associated with poor prognosis and Lower response to chemotherapy in gastric cancersJoon Young Hur, Joseph Chao, Kyung Kim, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 26, 2014
Estimates of conditional survival in gastric cancer reveal a reduction of racial disparities with long-term follow-upDavid Luyimbazi, Rebecca A Nelson, Audrey H Choi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Immunotherapy-Based Neoadjuvant Treatment of Advanced Microsatellite Instability-High Gastric Cancer: A Case SeriesLouisa Liu, Yanghee Woo, Massimo D'Apuzzo, et al.
Journal of Gastrointestinal Oncology|January 4, 2019
Low ATM expression and progression-free and overall survival in advanced gastric cancer patients treated with first-line XELOX chemotherapySamuel J Klempner, Munveer S Bhangoo, Hubert Y Luu, et al.
International Journal of Molecular Sciences|March 3, 2021
Dissecting Response to Cancer Immunotherapy by Applying Bayesian Network Analysis to Flow Cytometry DataAndrei S Rodin, Grigoriy Gogoshin, Seth Hilliard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2018
Chemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric CancerRichard Li, Wei-Hsien Hou, Joseph Chao, et al.
Journal of Gastrointestinal Oncology|August 9, 2019
Analyzing the impact of neoadjuvant radiation dose on pathologic response and survival outcomes in esophageal and gastroesophageal cancersRichard Li, Ashwin Shinde, Scott Glaser, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Cancer Control : Journal of the Moffitt Cancer Center|May 7, 2019
Real-World Outcomes and Factors Associated With the Second-Line Treatment of Patients With Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaAfsaneh Barzi, Lisa M Hess, Yajun E Zhu, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 3, 2016
Assessment of the Double-Staple Technique for Esophagoenteric Anastomosis in Gastric CancerAudrey H Choi, Amanda Arrington, Ann Falor, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 2, 2014
Validation and feasibility of a caloric expenditure measuring device in women with early-stage breast cancerSarah Waliany, Christina M Dieli-Conwright, Paul H Frankel, et al.
Pathology, Research and Practice|February 25, 2020
High-level FGFR2 amplification is associated with poor prognosis and Lower response to chemotherapy in gastric cancersJoon Young Hur, Joseph Chao, Kyung Kim, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 26, 2014
Estimates of conditional survival in gastric cancer reveal a reduction of racial disparities with long-term follow-upDavid Luyimbazi, Rebecca A Nelson, Audrey H Choi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Immunotherapy-Based Neoadjuvant Treatment of Advanced Microsatellite Instability-High Gastric Cancer: A Case SeriesLouisa Liu, Yanghee Woo, Massimo D'Apuzzo, et al.
Journal of Gastrointestinal Oncology|January 4, 2019
Low ATM expression and progression-free and overall survival in advanced gastric cancer patients treated with first-line XELOX chemotherapySamuel J Klempner, Munveer S Bhangoo, Hubert Y Luu, et al.
International Journal of Molecular Sciences|March 3, 2021
Dissecting Response to Cancer Immunotherapy by Applying Bayesian Network Analysis to Flow Cytometry DataAndrei S Rodin, Grigoriy Gogoshin, Seth Hilliard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2018
Chemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric CancerRichard Li, Wei-Hsien Hou, Joseph Chao, et al.
Journal of Gastrointestinal Oncology|August 9, 2019
Analyzing the impact of neoadjuvant radiation dose on pathologic response and survival outcomes in esophageal and gastroesophageal cancersRichard Li, Ashwin Shinde, Scott Glaser, et al.
Pageof 12